Bonne Biesma
's-hertogenbosch, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patients.
Journal: Frontiers in immunology
Published: December 08, 2025
Innovative therapeutic cancer vaccine PDC∗lung01 with or without anti-PD-1: an open-label, dose-escalation phase I/II study in non-small-cell lung cancer.
Journal: ESMO open
Published: May 27, 2025
Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment.
Journal: Clinical pharmacology and therapeutics
Published: February 03, 2025
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 05, 2023
Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial.
Journal: Cancer chemotherapy and pharmacology
Published: July 10, 2022
Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.
Journal: Clinical lung cancer
Published: August 13, 2021
Hyperhydration with cisplatin does not influence pemetrexed exposure.
Journal: British journal of clinical pharmacology
Published: April 08, 2021
Toxicity of pemetrexed during renal impairment explained-Implications for safe treatment.
Journal: International journal of cancer
Published: April 02, 2021
Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response.
Journal: EBioMedicine
Published: July 23, 2020
International real-world study of DLL3 expression in patients with small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 06, 2020
Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial.
Journal: The Lancet. Respiratory medicine
Published: March 13, 2020
Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial.
Journal: Frontiers in oncology
Published: March 04, 2020
Last Updated: 09/26/2026